1. Home
  2. NMRA vs KTF Comparison

NMRA vs KTF Comparison

Compare NMRA & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • KTF
  • Stock Information
  • Founded
  • NMRA 2019
  • KTF 1988
  • Country
  • NMRA United States
  • KTF United States
  • Employees
  • NMRA N/A
  • KTF N/A
  • Industry
  • NMRA
  • KTF Finance Companies
  • Sector
  • NMRA
  • KTF Finance
  • Exchange
  • NMRA Nasdaq
  • KTF Nasdaq
  • Market Cap
  • NMRA 291.5M
  • KTF 337.7M
  • IPO Year
  • NMRA 2023
  • KTF N/A
  • Fundamental
  • Price
  • NMRA $2.50
  • KTF $9.17
  • Analyst Decision
  • NMRA Buy
  • KTF
  • Analyst Count
  • NMRA 8
  • KTF 0
  • Target Price
  • NMRA $7.43
  • KTF N/A
  • AVG Volume (30 Days)
  • NMRA 2.3M
  • KTF 103.3K
  • Earning Date
  • NMRA 11-06-2025
  • KTF 01-01-0001
  • Dividend Yield
  • NMRA N/A
  • KTF 3.54%
  • EPS Growth
  • NMRA N/A
  • KTF N/A
  • EPS
  • NMRA N/A
  • KTF 0.39
  • Revenue
  • NMRA N/A
  • KTF N/A
  • Revenue This Year
  • NMRA N/A
  • KTF N/A
  • Revenue Next Year
  • NMRA N/A
  • KTF N/A
  • P/E Ratio
  • NMRA N/A
  • KTF $23.10
  • Revenue Growth
  • NMRA N/A
  • KTF N/A
  • 52 Week Low
  • NMRA $0.61
  • KTF $7.40
  • 52 Week High
  • NMRA $14.09
  • KTF $9.12
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 68.71
  • KTF 51.86
  • Support Level
  • NMRA $1.68
  • KTF $9.18
  • Resistance Level
  • NMRA $2.72
  • KTF $9.25
  • Average True Range (ATR)
  • NMRA 0.20
  • KTF 0.06
  • MACD
  • NMRA 0.08
  • KTF -0.02
  • Stochastic Oscillator
  • NMRA 81.89
  • KTF 23.30

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About KTF DWS Municipal Income Trust

DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.

Share on Social Networks: